155mm Shell Production Cannot Keep Pace With Wartime Consumption Rates

The United States produces approximately 40,000 155mm artillery rounds per month as of mid-2025, despite a target of 100,000 rounds per month set for October 2025. Before the Ukraine war, U.S. monthly output was just 14,400 rounds. Even with a nearly threefold increase, production remains far below what a single theater of conflict consumes: Ukraine alone requires 200,000 to 356,000 rounds per month to hold its front lines. This matters because artillery remains the dominant killer on the modern battlefield. When shell supply falls short, defenders cede territory and attackers stall. The gap between production and consumption means that any NATO member drawn into a high-intensity conflict would exhaust national stockpiles in weeks, not months, and resupply would take years to catch up. The U.S. Army moved from one shell-body production facility to four, but the constraint is not steel casings; it is propellant charges, fuzes, and explosives fill, each of which has its own bottleneck. The problem persists because Western defense procurement was optimized for low-rate peacetime production over three decades of counterinsurgency wars. Contracts rewarded efficiency and just-in-time delivery, not surge capacity. Over fifty mergers and acquisitions consolidated the munitions industrial base into a handful of primes, eliminating redundant production lines that would now be essential. Rebuilding those lines requires not just capital but regulatory approvals, environmental permits for energetics handling, and a trained workforce that does not currently exist at scale. Russia, by contrast, produces an estimated 4.5 million shells per year, roughly four times the combined NATO output of 1.2 million. This asymmetry is not a temporary gap but a structural one rooted in the West's post-Cold War decision to treat ammunition as a commodity rather than a strategic reserve.